American Journal of Kidney Diseases
Volume 49, Issue 3 , Pages 349-351 , March 2007

A Call to Action on World Kidney Day, March 8, 2007

  • William G. Couser, MD

      Affiliations

    • President, International Society of Nephrology
    • ,
  • Sudhir Shah, MD

      Affiliations

    • President, International Federation of Kidney Foundations

References 

  1. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1–12
  2. Gansevoort RT, van der Heij B, Stegeman CA, et al. Trends in the incidence of treated end-stage renal failure in the Netherlands: hope for the future?. Kidney Int Suppl. 2004;92:S7–S10
  3. Uhlig K, Macleod A, Craig J, et al. Grading evidence and recommendations for clinical practice guidelines in nephrology (A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)). Kidney Int. 2006;70:2058–2065
  4. El Nahas ME. The global challenge of chronic kidney disease (Nephrology Forum). Kidney Int. 2005;68:2918–2929
  5. Hallan SI, Coresh J, Astor BC, et al. International Comparison of the Relationship of Chronic Kidney Disease Prevalence and ESRD Risk. J Am Soc Nephrol. 2006;17:2275–2284
  6. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalisation. New Engl J Med. 2004;351:1296–1305
  7. Weiner DE, Tabatabai S, Tighiouart H, et al. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis. 2006;48:392–401
  8. Keith D, Nicholls G, Guillion C, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organisation. Arch Intern Med. 2004;164:659–663
  9. Mann JFE, Gerstein HC, Pogue J, et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med. 2006;134:629–636
  10. Solomon SD, Rice MM, Jablonski KA, et al. Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial. Circulation. 2006;114:26–31
  11. Asselbergs FW, Diercks GF, Hillege HL, et al. Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation. 2004;110:2809–2816
  12. Ibsen H, Wachtell K, Olsen MH, et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: The LIFE Study. Kidney Int Suppl. 2004;92:S56–S58
  13. Yuyun MF, Adler AI, Wareham NJ. What is the evidence that microalbuminuria is a predictor of cardiovascular disease events?. Curr Opin in Nephrol Hypertension. 2006;14:271–276
  14. World Health Organization. Preventing Chronic Diseases (A vital investment). Geneva, Switzerland: World Health Organization; 2005;
  15. Codreanu I, Perico N, Sharma SK, Schieppati A, Remuzzi G. Prevention programmes of progressive renal disease in developing nations. Nephrology. 2006;11:321–328
  16. Perico N, Plata R, Anabaya A, et al. Strategies for national health care systems in emerging countries: the case of screening and prevention of renal disease progression in Bolivia. Kidney Int Suppl. 2005;97:S87–S94
  17. Mani MK. Nephrologists sans frontières: preventing chronic kidney disease on a shoestring. Kidney Int. 2006;70:821–823
  18. Atthobari J, Asselbergs FW, Boersma C, et al. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: a pharmacoeconomic analysis linked to the PREVEND and PREVEND-IT study. Clin Therapeutics. 2006;28:432–444
  19. Levey AS, Andreoli SP, DuBose T, Provenzano R, Collins AJ. Chronic kidney disease: Common, harmful and treatable—World Kidney Day 2007. Am J Kidney Dis. 2007;49:175–179

PII: S0272-6386(07)00122-9

doi: 10.1053/j.ajkd.2007.01.023

American Journal of Kidney Diseases
Volume 49, Issue 3 , Pages 349-351 , March 2007

Article Tools